Quercetin inhibits necroptosis in cardiomyocytes after ischemia-reperfusion via DNA-PKcs-SIRT5-orchestrated mitochondrial quality control
- PMID: 38447978
- DOI: 10.1002/ptr.8177
Quercetin inhibits necroptosis in cardiomyocytes after ischemia-reperfusion via DNA-PKcs-SIRT5-orchestrated mitochondrial quality control
Abstract
We investigated the mechanism by which quercetin preserves mitochondrial quality control (MQC) in cardiomyocytes subjected to ischemia-reperfusion stress. An enzyme-linked immunosorbent assay was employed in the in vivo experiments to assess myocardial injury markers, measure the transcript levels of SIRT5/DNAPK-cs/MLKL during various time intervals of ischemia-reperfusion, and observe structural changes in cardiomyocytes using transmission electron microscopy. In in vitro investigations, adenovirus transfection was employed to establish a gene-modified model of DNA-PKcs, and primary cardiomyocytes were obtained from a mouse model with modified SIRT5 gene. Reverse transcription polymerase chain reaction, laser confocal microscopy, immunofluorescence localization, JC-1 fluorescence assay, Seahorse energy analysis, and various other assays were applied to corroborate the regulatory influence of quercetin on the MQC network in cardiomyocytes after ischemia-reperfusion. In vitro experiments demonstrated that ischemia-reperfusion injury caused changes in the structure of the myocardium. It was seen that quercetin had a beneficial effect on the myocardial tissue, providing protection. As the ischemia-reperfusion process continued, the levels of DNA-PKcs/SIRT5/MLKL transcripts were also found to change. In vitro investigations revealed that quercetin mitigated cardiomyocyte injury caused by mitochondrial oxidative stress through DNA-PKcs, and regulated mitophagy and mitochondrial kinetics to sustain optimal mitochondrial energy metabolism levels. Quercetin, through SIRT5 desuccinylation, modulated the stability of DNA-PKcs, and together they regulated the "mitophagy-unfolded protein response." This preserved the integrity of mitochondrial membrane and genome, mitochondrial dynamics, and mitochondrial energy metabolism. Quercetin may operate synergistically to oversee the regulation of mitophagy and the unfolded protein response through DNA-PKcs-SIRT5 interaction.
Keywords: SIRT5–DNA–PKcs; mitochondrial quality control; mitochondrial unfolded protein response; mitophagy; necroptosis; quercetin.
© 2024 John Wiley & Sons Ltd.
Similar articles
-
SIRT5-Related Desuccinylation Modification Contributes to Quercetin-Induced Protection against Heart Failure and High-Glucose-Prompted Cardiomyocytes Injured through Regulation of Mitochondrial Quality Surveillance.Oxid Med Cell Longev. 2021 Sep 23;2021:5876841. doi: 10.1155/2021/5876841. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 34603599 Free PMC article.
-
DNA-PKcs promotes cardiac ischemia reperfusion injury through mitigating BI-1-governed mitochondrial homeostasis.Basic Res Cardiol. 2020 Jan 9;115(2):11. doi: 10.1007/s00395-019-0773-7. Basic Res Cardiol. 2020. PMID: 31919590
-
Zishen Huoxue decoction (ZSHX) alleviates ischemic myocardial injury (MI) via Sirt5-β-tubulin mediated synergistic mechanism of "mitophagy-unfolded protein response" and mitophagy.Chin J Nat Med. 2025 Mar;23(3):311-321. doi: 10.1016/S1875-5364(25)60838-7. Chin J Nat Med. 2025. PMID: 40122661
-
SIRT5 and post-translational protein modifications: A potential therapeutic target for myocardial ischemia-reperfusion injury with regard to mitochondrial dynamics and oxidative metabolism.Eur J Pharmacol. 2018 Jan 5;818:410-418. doi: 10.1016/j.ejphar.2017.11.005. Epub 2017 Nov 14. Eur J Pharmacol. 2018. PMID: 29154835 Review.
-
Mitochondrial quality control in cardiac microvascular ischemia-reperfusion injury: New insights into the mechanisms and therapeutic potentials.Pharmacol Res. 2020 Jun;156:104771. doi: 10.1016/j.phrs.2020.104771. Epub 2020 Mar 28. Pharmacol Res. 2020. PMID: 32234339 Review.
Cited by
-
Nuclear receptor subfamily 4 group A member 1 promotes myocardial ischemia/reperfusion injury through inducing mitochondrial fission factor-mediated mitochondrial fragmentation and inhibiting FUN14 domain containing 1-depedent mitophagy.Int J Biol Sci. 2024 Aug 19;20(11):4458-4475. doi: 10.7150/ijbs.95853. eCollection 2024. Int J Biol Sci. 2024. PMID: 39247823 Free PMC article.
-
Cardiovascular protection of YiyiFuzi powder and the potential mechanisms through modulating mitochondria-endoplasmic reticulum interactions.Front Pharmacol. 2024 Jun 24;15:1405545. doi: 10.3389/fphar.2024.1405545. eCollection 2024. Front Pharmacol. 2024. PMID: 38978978 Free PMC article. Review.
-
Histone deacetylase 4: A therapeutic target for cardiovascular diseases (Review).Int J Mol Med. 2025 Oct;56(4):158. doi: 10.3892/ijmm.2025.5599. Epub 2025 Aug 1. Int J Mol Med. 2025. PMID: 40747664 Free PMC article. Review.
-
Mitochondrial ultrastructural pathology in diabetic cardiomyopathy: integrated analysis via scanning electron microscopy and 3D visualization imaging.Cardiovasc Diabetol. 2025 Aug 13;24(1):331. doi: 10.1186/s12933-025-02884-5. Cardiovasc Diabetol. 2025. PMID: 40804395 Free PMC article.
-
Shaping cardiac destiny: the role of post-translational modifications on endoplasmic reticulum - mitochondria crosstalk in cardiac remodeling.Front Pharmacol. 2024 Oct 11;15:1423356. doi: 10.3389/fphar.2024.1423356. eCollection 2024. Front Pharmacol. 2024. PMID: 39464632 Free PMC article. Review.
References
REFERENCES
-
- Adamowicz, M., d'Adda di Fagagna, F., & Vermezovic, J. (2018). NOTCH1 modulates activity of DNA‐PKcs. Mutation Research, 808, 20–27.
-
- Chang, X., Ismail, N. I., Rahman, A., Xu, D., Chan, R. W. Y., Ong, S. G., & Ong, S. B. (2023). Long COVID‐19 and the heart: Is cardiac mitochondria the missing link? Antioxidants & Redox Signaling, 38(7–9), 599–618.
-
- Chang, X., Li, Y., Cai, C., Wu, F., He, J., Zhang, Y., Zhong, J., Tan, Y., Liu, R., Zhu, H., & Zhou, H. (2022). Mitochondrial quality control mechanisms as molecular targets in diabetic heart. Metabolism, 137, 155313.
-
- Chang, X., Li, Y., Liu, J., Wang, Y., Guan, X., Wu, Q., Zhou, Y., Zhang, X., Chen, Y., Huang, Y., & Liu, R. (2023). ß‐tubulin contributes to Tongyang Huoxue decoction‐induced protection against hypoxia/reoxygenation‐induced injury of sinoatrial node cells through SIRT1‐mediated regulation of mitochondrial quality surveillance. Phytomedicine, 108, 154502.
-
- Chang, X., Liu, J., Wang, Y., Guan, X., & Liu, R. (2023). Mitochondrial disorder and treatment of ischemic cardiomyopathy: Potential and advantages of Chinese herbal medicine. Biomedicine & Pharmacotherapy, 159, 114171.
MeSH terms
Substances
Grants and funding
- ZZ16-YQ-021/Special Program for Training Outstanding Young Talents of Chinese Academy of Traditional Chinese Medicine
- 2021/Chinese Academy of Chinese Medical Sciences Doctoral Talents Training Fund
- 2022s481/Innovative cultivation project of Guang'anmen Hospital, Chinese Academy of Chinese Medical Sciences
- 82305204/the National Natural Science Foundation of China
- CI2022E012XB/Special Project on Academic Inheritance and Communication, China Academy of Chinese Medical Sciences
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous